Massachusetts · Nonprofit
NUCLEATE BIO INC
NUCLEATE BIO INC (Massachusetts) receives grants from 9 organizations whose IRS filings report $567,500 to it, the largest being Mercatus Center Inc ($148,000). 4 of them have funded it in more than one year.
- Revenue FY2025
- $1.8M
- Funders on record
- 9
- Grants received
- $568k
- Net assets
- $495k
What Nucleate Bio Inc does
Mission
Empower tomorrow's biotech leaders by educating today's acedemic trainees
As stated on its FY2025 Form 990.
Program
See schedule oactivator program - the goal of the nucleate "activator" program is to provide a rigorous and comprehensive educational experience to future biotech entrepreneurs. Our core curriculum consists of bi-weekly workshops held throughout the spring, and culminates in a final pitch event where teams showcase their companies to a large audience of industry stakeholders.the workshops, created in collaboration with our world-class advisors, are structured to address critical aspects of early-stage life science company formation. Together, they are designed to provide a roadmap for translating and commercializing early-stage technology concepts.each workshop consists of three parts:1) pre-work - teams prepare slides and discussion topics ahead of each workshop, which are circulated to workshop experts in advance. At the end of the program, these slides will form the building blocks of their final 10-15 minute polished pitch deck.2) hands-on feedback - during the 2-hour workshops, teams are paired with experts relevant to their targeted market and/or technology who provide feedback on the materials presented by the teams.3) post-work - after each workshop, teams integrate expert…
$1,696,750 spentof which $66,770 as grants$13,590 earned by the program100% of program spending
The program described on its FY2025 Form 990. Program spending in total: $1,696,750.
The organization over time
Each line starts at 100 in 2021, so what you read is the shape rather than the size: 150 means half as much again as 2021, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2021 to 2022, from $255k to $659k (+159%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
99% of NUCLEATE BIO INC’s revenue is contributions — more reliant on donations than three-quarters of its peers (67% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 1 of the last 5 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Who funds it, year by year
2021 → 2023: the base broadened from 1 funder to 6 funders, grant income rose $100k → $222k.
1 of 9 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 18% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of NUCLEATE BIO INC’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
NUCLEATE BIO INC leans on a few funders — its largest provides 26% of grant income and the top three 69%; half comes from just 2 funders.
the vertical line marks half of all grant income — 2 funders to its left
50% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund NUCLEATE BIO INC.
Largest funder’s share by year: 2021 100% · 2022 51% · 2023 45% — diversifying over time.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Where its funders are
NUCLEATE BIO INC draws 94% of its grant income from funders outside Massachusetts, across 7 states in all.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $100k arriving through sponsors registered in 1 state is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
NUCLEATE BIO INC has grown faster than three-quarters of the 210 science & tech nonprofits its size.
this organization peer median middle 50% of peers· 210 science & tech nonprofits $1M–$10M, FY2025
Organizations like NUCLEATE BIO INC
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In Massachusetts
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
85% of spending goes to programs.
Governance
Footprint & structure
Files a return copy in 1 state
Screen this organization
A dated, signed PDF of the compliance screen for NUCLEATE BIO INC: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds NUCLEATE BIO INC?
- NUCLEATE BIO INC (Massachusetts) receives grants from 9 organizations whose IRS filings report $567,500 to it, the largest being Mercatus Center Inc ($148,000). 4 of them have funded it in more than one year.
- How many funders does NUCLEATE BIO INC have?
- IRS filings report 9 organizations giving $567,500 in grants to NUCLEATE BIO INC, 4 of which have funded it in more than one year.
- Who is the largest funder of NUCLEATE BIO INC?
- Mercatus Center Inc is the largest funder on record, with $148,000 in grants. The full list of funders is on this page.
- How can an organization like NUCLEATE BIO INC find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in Massachusetts. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2021–2025), and the filings of 9 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing